Skip to main content
. 2020 Apr 16;10(4):613. doi: 10.3390/biom10040613

Figure 5.

Figure 5

Evaluation of miR-26b-5p, miR-142-5p, miR-194-5p, miR-301a-5p and miR-3074-5p expression levels in rectal tumor tissue samples collected from patients who received long-course neoadjuvant treatment. The sample cohort was collected from 24 patients diagnosed with rectal cancer and contained three groups and included rectal tumor samples collected from patients before long course neoadjuvant treatment (n = 24), and normal (n = 24) and tumor tissue (n = 24) samples collected from the same patients after the therapy. (A) Box plots representing the expression of miR-3074-5p, miR-301a-5p and miR-142-5p in rectal tumor tissues collected before and after the therapy. (B) Box plots representing the expression of miR-194-5p, miR-26b-5p and miR-142-5p in rectal tumor and adjacent normal tissue samples collected from the same patients after the therapy. RNU48 was used as the internal control for the data normalization. * p < 0.05; ** p < 0.01; *** p < 0.001.